Overview

Study to Evaluate the Pharmacokinetics of Mucinex® 1200 mg Extended-Release Tablet

Status:
Completed
Trial end date:
2011-10-15
Target enrollment:
Participant gender:
Summary
Characterize and assess PK of guaifenesin in Mucinex® 1200 mg ER Bi-Layer Tablet
Phase:
Phase 1
Details
Lead Sponsor:
Reckitt Benckiser LLC
Treatments:
Chlorpheniramine, phenylpropanolamine drug combination
Guaifenesin
Phenylpropanolamine